ETF Holdings Breakdown of NEO

NEO institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	104,986	USD 832,539
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	79,231	USD 628,302
2025-09-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	8,705	USD 69,031 0.8%
Total =		192,922	USD 1,529,872

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with NEO

Stephens Forecasts Strong Price Appreciation for NeoGenomics (NASDAQ:NEO) Stock

NeoGenomics (NASDAQ:NEO – Get Free Report) had its target price boosted by equities researchers at Stephens from $6.50 to $11.00 in a note issued to investors on Tuesday, Marketbeat.com reports. The firm currently has an “overweight” rating on the medical research company’s stock. Stephens’ price target points to a potential upside of 34.31% from the […] - 2025-09-04 04:42:49

NeoGenomics (NASDAQ:NEO) Price Target Raised to $14.00

NeoGenomics (NASDAQ:NEO – Free Report) had its price target upped by Needham & Company LLC from $8.00 to $14.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the medical research company’s stock. Several other brokerages have also recently commented on NEO. Wall Street Zen upgraded shares of […] - 2025-09-01 02:59:14

Maryland State Retirement & Pension System Decreases Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Maryland State Retirement & Pension System trimmed its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 13.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,401 shares of the medical research company’s stock after selling 5,877 shares […] - 2025-08-17 05:21:02

Stifel Nicolaus Forecasts Strong Price Appreciation for Neo Performance Materials (TSE:NEO) Stock

Neo Performance Materials (TSE:NEO – Get Free Report) had its price objective hoisted by investment analysts at Stifel Nicolaus from C$17.50 to C$22.00 in a research report issued on Wednesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price target would indicate a potential upside of 30.41% from the company’s […] - 2025-08-15 02:14:50

NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of “Hold” by Brokerages

Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have earned a consensus rating of “Hold” from the twelve brokerages that are presently covering the stock, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target […] - 2025-08-12 04:43:02

NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Blair William & Co. IL

Blair William & Co. IL trimmed its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 25.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 65,638 shares of the medical research company’s stock after selling 22,312 shares during the quarter. Blair William […] - 2025-08-11 05:52:55

Harbour Investments Inc. Reduces Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Harbour Investments Inc. reduced its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 50.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 2,835 shares of the medical research company’s stock after selling 2,937 shares during the period. Harbour Investments Inc.’s holdings in NeoGenomics were worth $27,000 as of its most recent SEC filing. […] - 2025-08-11 05:14:54

NeoGenomics, Inc. (NASDAQ:NEO) Shares Acquired by Federated Hermes Inc.

Federated Hermes Inc. increased its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 10.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 161,428 shares of the medical research company’s stock after acquiring an additional 15,887 shares during the period. […] - 2025-08-06 05:16:55

Piper Sandler Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price

NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by Piper Sandler from $12.00 to $11.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s target price indicates a potential upside of 95.73% from the stock’s previous close. […] - 2025-08-06 02:18:47

NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by TD Asset Management Inc

TD Asset Management Inc cut its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 57.5% during the first quarter, HoldingsChannel reports. The firm owned 89,910 shares of the medical research company’s stock after selling 121,522 shares during the period. TD Asset Management Inc’s holdings in NeoGenomics were worth $853,000 as of its most recent […] - 2025-08-05 05:32:52

NeoGenomics (NASDAQ:NEO) Given Market Perform Rating at William Blair

William Blair reaffirmed their market perform rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a report published on Tuesday, MarketBeat.com reports. A number of other equities analysts also recently commented on NEO. Leerink Partners downgraded NeoGenomics from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock […] - 2025-07-30 04:34:56

NeoGenomics (NASDAQ:NEO) Hits New 52-Week Low Following Weak Earnings

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $5.00 and last traded at $5.41, with a volume of 1442341 shares trading hands. The stock had previously closed at $6.46. The medical research company reported ($0.08) […] - 2025-07-30 02:14:46

Nisa Investment Advisors LLC Has $177,000 Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)

Nisa Investment Advisors LLC lowered its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 56.7% in the first quarter, Holdings Channel.com reports. The institutional investor owned 18,698 shares of the medical research company’s stock after selling 24,517 shares during the quarter. Nisa Investment Advisors LLC’s holdings in NeoGenomics were worth $177,000 as of its […] - 2025-07-18 05:13:01

NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lessened its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 5.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 63,233 shares of the medical research company’s stock after selling 3,533 shares during the quarter. Illinois […] - 2025-07-04 04:46:51

Neo Performance Materials (TSE:NEO) Hits New 1-Year High After Dividend Announcement

Neo Performance Materials Inc. (TSE:NEO – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday after the company announced a dividend. The company traded as high as C$12.81 and last traded at C$12.54, with a volume of 171331 shares trading hands. The stock had previously closed at C$12.27. The newly announced […] - 2025-06-20 02:10:48

ProShare Advisors LLC Increases Position in NeoGenomics, Inc. (NASDAQ:NEO)

ProShare Advisors LLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 44.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,445 shares of the medical research company’s stock after purchasing an additional 11,831 shares during the quarter. […] - 2025-05-26 05:49:09

Tower Research Capital LLC TRC Cuts Stake in NeoGenomics, Inc. (NASDAQ:NEO)

Tower Research Capital LLC TRC cut its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 80.8% during the 4th quarter, HoldingsChannel reports. The firm owned 2,449 shares of the medical research company’s stock after selling 10,292 shares during the quarter. Tower Research Capital LLC TRC’s holdings in NeoGenomics were worth $40,000 as of its […] - 2025-05-14 04:24:47

Neo Performance Materials (TSE:NEO) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Neo Performance Materials (TSE:NEO – Get Free Report) had its target price boosted by equities research analysts at Stifel Nicolaus from C$16.50 to C$17.50 in a research report issued to clients and investors on Monday,BayStreet.CA reports. Stifel Nicolaus’ price target would suggest a potential upside of 58.80% from the stock’s current price. Neo Performance Materials […] - 2025-05-14 02:24:49

Schonfeld Strategic Advisors LLC Sells 54,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO)

Schonfeld Strategic Advisors LLC cut its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 76.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 16,280 shares of the medical research company’s stock after selling 54,330 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in NeoGenomics were worth $268,000 as of its […] - 2025-05-13 05:42:51

NeoGenomics (NASDAQ:NEO) Upgraded to Hold at StockNews.com

NeoGenomics (NASDAQ:NEO – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Tuesday. Other equities research analysts also recently issued reports about the company. The Goldman Sachs Group cut their price target on NeoGenomics from $15.00 to $10.00 and set a […] - 2025-05-13 04:28:54

Voya Investment Management LLC Sells 5,003,158 Shares of NeoGenomics, Inc. (NASDAQ:NEO)

Voya Investment Management LLC trimmed its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 98.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 61,688 shares of the medical research company’s stock after selling 5,003,158 shares during the quarter. Voya […] - 2025-05-07 05:57:02

Hsbc Holdings PLC Trims Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Hsbc Holdings PLC reduced its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 7.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,569 shares of the medical research company’s stock after selling 2,430 shares during the quarter. Hsbc Holdings PLC’s holdings […] - 2025-05-07 04:56:56

Needham & Company LLC Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price

NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by research analysts at Needham & Company LLC from $18.00 to $8.50 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Needham & Company LLC’s target price would indicate a potential upside […] - 2025-05-01 02:52:52

NeoGenomics (NASDAQ:NEO) Shares Gap Down Following Weak Earnings

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report)’s share price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $9.97, but opened at $9.64. NeoGenomics shares last traded at $7.59, with a volume of 85,531 shares changing hands. The medical research company reported ($0.08) earnings per […] - 2025-04-30 03:12:52

Barclays PLC Has $3.95 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Barclays PLC increased its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 239,438 shares of the medical research company’s stock after buying an additional 8,537 shares during the quarter. Barclays PLC […] - 2025-04-28 05:34:55

Invesco Ltd. Decreases Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Invesco Ltd. reduced its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 6.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 410,967 shares of the medical research company’s stock after selling 27,789 shares during the quarter. Invesco Ltd. owned approximately 0.32% […] - 2025-04-25 05:08:53

Sterling Capital Management LLC Grows Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)

Sterling Capital Management LLC lifted its position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 788.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,706 shares of the medical research company’s stock after buying an additional 3,289 shares during the period. […] - 2025-04-24 05:46:54

Rockefeller Capital Management L.P. Acquires 16,831 Shares of NeoGenomics, Inc. (NASDAQ:NEO)

Rockefeller Capital Management L.P. grew its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 49.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,082 shares of the medical research company’s stock after acquiring an additional 16,831 shares during the period. Rockefeller Capital […] - 2025-04-23 05:41:01

Federated Hermes Inc. Raises Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)

Federated Hermes Inc. increased its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 4.4% in the fourth quarter, Holdings Channel reports. The firm owned 145,541 shares of the medical research company’s stock after acquiring an additional 6,086 shares during the period. Federated Hermes Inc.’s holdings in NeoGenomics were worth $2,399,000 as of […] - 2025-04-14 05:48:59

Geode Capital Management LLC Has $49.99 Million Stake in NeoGenomics, Inc. (NASDAQ:NEO)

Geode Capital Management LLC reduced its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 0.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,032,676 shares of the medical research company’s stock after selling 19,130 shares during the quarter. Geode Capital Management LLC’s holdings in NeoGenomics were worth $49,990,000 at […] - 2025-04-14 05:00:54

Back to Listing

Disclaimer